219 related articles for article (PubMed ID: 23858959)
61. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy.
Singh A; Dilnawaz F; Mewar S; Sharma U; Jagannathan NR; Sahoo SK
ACS Appl Mater Interfaces; 2011 Mar; 3(3):842-56. PubMed ID: 21370886
[TBL] [Abstract][Full Text] [Related]
62. Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy.
Li T; Gendelman HE; Zhang G; Puligujja P; McMillan JM; Bronich TK; Edagwa B; Liu XM; Boska MD
Int J Nanomedicine; 2015; 10():3779-90. PubMed ID: 26082630
[TBL] [Abstract][Full Text] [Related]
63. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma.
Emamgholizadeh Minaei S; Khoei S; Khoee S; Karimi MR
Int J Biochem Cell Biol; 2019 Mar; 108():72-83. PubMed ID: 30660689
[TBL] [Abstract][Full Text] [Related]
64. Superparamagnetic Fe
Yin T; Huang P; Gao G; Shapter JG; Shen Y; Sun R; Yue C; Zhang C; Liu Y; Zhou S; Cui D
Sci Rep; 2016 Nov; 6():36187. PubMed ID: 27824072
[TBL] [Abstract][Full Text] [Related]
65. Folate-bovine serum albumin functionalized polymeric micelles loaded with superparamagnetic iron oxide nanoparticles for tumor targeting and magnetic resonance imaging.
Li H; Yan K; Shang Y; Shrestha L; Liao R; Liu F; Li P; Xu H; Xu Z; Chu PK
Acta Biomater; 2015 Mar; 15():117-26. PubMed ID: 25595473
[TBL] [Abstract][Full Text] [Related]
66. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells.
Liao Z; Wang H; Lv R; Zhao P; Sun X; Wang S; Su W; Niu R; Chang J
Langmuir; 2011 Mar; 27(6):3100-5. PubMed ID: 21341768
[TBL] [Abstract][Full Text] [Related]
67. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
[TBL] [Abstract][Full Text] [Related]
68. hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin.
Ghareghomi S; Ahmadian S; Zarghami N; Hemmati S
Life Sci; 2021 Jul; 277():119621. PubMed ID: 34004255
[TBL] [Abstract][Full Text] [Related]
69. In vitro cell uptake of biocompatible magnetite/chitosan nanoparticles with high magnetization: a single-step synthesis approach for in-situ-modified magnetite by amino groups of chitosan.
Wang Y; Li B; Xu F; Jia D; Feng Y; Zhou Y
J Biomater Sci Polym Ed; 2012; 23(7):843-60. PubMed ID: 21418750
[TBL] [Abstract][Full Text] [Related]
70. Carbon encapsulated iron oxide nanoparticles surface engineered with polyethylene glycol-folic acid to induce selective hyperthermia in folate over expressed cancer cells.
Sadhasivam S; Savitha S; Wu CJ; Lin FH; Stobiński L
Int J Pharm; 2015 Mar; 480(1-2):8-14. PubMed ID: 25601197
[TBL] [Abstract][Full Text] [Related]
71. Augmented cellular uptake of nanoparticles using tea catechins: effect of surface modification on nanoparticle-cell interaction.
Lu YC; Luo PC; Huang CW; Leu YL; Wang TH; Wei KC; Wang HE; Ma YH
Nanoscale; 2014 Sep; 6(17):10297-306. PubMed ID: 25069428
[TBL] [Abstract][Full Text] [Related]
72. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
73. Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles.
Hao J; Tong T; Jin K; Zhuang Q; Han T; Bi Y; Wang J; Wang X
Int J Nanomedicine; 2017; 12():2279-2292. PubMed ID: 28392687
[TBL] [Abstract][Full Text] [Related]
74. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting.
Kaaki K; Hervé-Aubert K; Chiper M; Shkilnyy A; Soucé M; Benoit R; Paillard A; Dubois P; Saboungi ML; Chourpa I
Langmuir; 2012 Jan; 28(2):1496-505. PubMed ID: 22172203
[TBL] [Abstract][Full Text] [Related]
75. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
76. In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model.
Sun Z; Song X; Li X; Su T; Qi S; Qiao R; Wang F; Huan Y; Yang W; Wang J; Nie Y; Wu K; Gao M; Cao F
Nanoscale; 2014 Nov; 6(23):14343-53. PubMed ID: 25327162
[TBL] [Abstract][Full Text] [Related]
77. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging.
Li J; Zheng L; Cai H; Sun W; Shen M; Zhang G; Shi X
Biomaterials; 2013 Nov; 34(33):8382-92. PubMed ID: 23932250
[TBL] [Abstract][Full Text] [Related]
78. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.
Oyewumi MO; Yokel RA; Jay M; Coakley T; Mumper RJ
J Control Release; 2004 Mar; 95(3):613-26. PubMed ID: 15023471
[TBL] [Abstract][Full Text] [Related]
79. In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells.
Nasiri R; Hamzehalipour Almaki J; Idris AB; Abdul Majid FA; Nasiri M; Salouti M; Irfan M; Amini N; Marvibaigi M
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1147-58. PubMed ID: 27612812
[TBL] [Abstract][Full Text] [Related]
80. Polymeric nanocarriers for magnetic targeted drug delivery: preparation, characterization, and in vitro and in vivo evaluation.
Licciardi M; Scialabba C; Fiorica C; Cavallaro G; Cassata G; Giammona G
Mol Pharm; 2013 Dec; 10(12):4397-407. PubMed ID: 24168360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
